机译:Untidelone Plus Capecitabine与Capecitabine单独用于大量预处理的转移性乳腺癌对蒽氟胞和紫杉烷的难治性:多期,开放标签,优越性,第3阶段,随机对照试验
Chinese Acad Med Sci Canc Hosp Natl Canc Ctr Dept Med Oncol Beijing Peoples R China;
Liaoning Canc Hosp &
Inst Shenyang Peoples R China;
Harbin Med Univ Canc Hosp Dept Med Oncol Harbin Peoples R China;
Sun Yat Sen Univ Ctr Canc Dept Med Oncol Guangzhou Guangdong Peoples R China;
307th Hosp Chinese PLA Beijing Peoples R China;
Zhejiang Canc Hosp Hangzhou Zhejiang Peoples R China;
Henan Canc Hosp Breast Canc Ctr Zhengzhou Peoples R China;
China Med Univ Hosp 1 Dept Med Oncol Shenyang Peoples R China;
Fudan Univ Ctr Canc Shanghai Peoples R China;
301st Hosp Chinese PLA Beijing Peoples R China;
Zhejiang Univ Sch Med Sir Run Run Shaw Hosp Hangzhou Zhejiang Peoples R China;
Tianjin Med Univ Dept Breast Oncol Canc Hosp Tianjin Peoples R China;
Peking Univ Canc Hosp Beijing Peoples R China;
Nankai Univ Tianjin Peoples Hosp Tianjin Peoples R China;
Shandong Univ Shandong Canc Hosp Jinan Peoples R China;
Nanjing Med Univ Affiliated Hosp 1 Nanjing Jiangsu Peoples R China;
Qingdao Univ Yantai Yuhuangding Hosp Yantai Peoples R China;
Sichuan Univ West China Hosp Chengdu Peoples R China;
Wuhan Union Hosp Tongji Med Coll Wuhan Peoples R China;
Shanghai Jiao Tong Univ Renji Hosp Shanghai Peoples R China;
Nantong Tumor Hosp Nantong Peoples R China;
Hebei Med Univ Tumor Hosp Shijiazhuang Peoples R China;
Fujian Med Univ Canc Hosp Fuzhou Peoples R China;
Sun Yat Sen Univ Ctr Canc Dept Med Oncol Guangzhou Guangdong Peoples R China;
Henan Canc Hosp Breast Canc Ctr Zhengzhou Peoples R China;
307th Hosp Chinese PLA Beijing Peoples R China;
Zhejiang Canc Hosp Hangzhou Zhejiang Peoples R China;
Beijing Biostar Technol Beijing Peoples R China;
Beijing Biostar Technol Beijing Peoples R China;
Chinese Acad Med Sci Canc Hosp Natl Canc Ctr Dept Med Oncol Beijing Peoples R China;
机译:Untidelone Plus Capecitabine与Capecitabine单独用于大量预处理的转移性乳腺癌对蒽氟胞和紫杉烷的难治性:多期,开放标签,优越性,第3阶段,随机对照试验
机译:Vinorelbine Plus Capecitabine的随机对照阶段II试验与Docetaxel Plus Capecitabine在蒽霉素 - 预处理患有转移性乳腺癌的妇女
机译:Uridelone Plus Capecitabine与Capecitabine进行重预处理转移性乳腺癌和CIPN:单一中心队列的分析
机译:Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
机译:伊立替康联合卡培他滨与卡培他滨单药治疗以前用蒽环类和紫杉烷类治疗的转移性乳腺癌患者的随机开放标签III期试验:继续试验(KCSG BR 11-01)
机译:Incotecan Plus Capecitabine的随机开放标签阶段III试验与先前用蒽环和紫杉烷治疗的转移性乳腺癌患者的Capecitabine单药治疗:进行试验(KCSG BR 11-01)